Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

PMGC Holdings (ELAB): Fifth Aerospace Acquisition in Twelve Months

PMGC Holdings is executing its aerospace and defence manufacturing roll-up with disciplined speed. The company announced the acquisition of A&B Aerospace, a precision machiningBusinessserving the aerospace sector, for $4.5 million — its fifth acquisition in the past twelve months and a further concrete step …

Nitish Kishor | 13 May 2026

Harrow Slips 7% to $35.50 in After-Hours Trading Despite Reaffirming $350–$365M Full-Year Guidance

Harrow (Nasdaq: HROW) fell 7 per cent to $35.50 in after-hours trading on Tuesday after the ophthalmic pharmaceutical company reported first-quarter revenue of $44.2 million — a figure that, on the surface, understates the underlying commercial momentum by the amount of a specific and …

Nitish Kishor | 12 May 2026

Exagen Closes Up 35% at $3.98 as Record Q1 Revenue and AVISE CTD Momentum Drive a Compelling Re-Rating

Exagen Inc. (Nasdaq: XGN) surged 35 per cent to close at $3.98 on Tuesday after the medical diagnostics company reported a first quarter that exceeded expectations on the metrics that matter most for a diagnosticsBusinessat this stage of its commercial development: volume, pricing, and …

Nitish Kishor | 12 May 2026

Liquidia Corporation Closes Up 25% at $53.13 as YUTREPIA Delivers Third Straight Profitable Quarter on $130M Sales

Liquidia Corporation (Nasdaq: LQDA) delivered one of the most emphatic commercial readouts in the pulmonary hypertension space on Tuesday, sending its shares 25 per cent higher to close at $53.13 as investors digested a first-quarter performance that left little room for equivocation. YUTREPIA, the …

Nitish Kishor | 12 May 2026

Actuate Therapeutics Closes Down 10% at $2.98 Despite FDA Clearing IND for Oral Elraglusib in Solid Tumours

Actuate Therapeutics (Nasdaq: ACTU) closed 10 per cent lower at $2.98 on Tuesday, in what may rank as one of the more counterintuitive market reactions of the session. The company had just announced that the US Food and Drug Administration had cleared its Investigational …

Nitish Kishor | 12 May 2026

Aditxt Closes Down 8% at $0.11 as Nasdaq Delisting Letter Leaves Company Without a Grace Period

Aditxt, Inc. (NASDAQ: ADTX) closed 8 per cent lower at $0.11 on Tuesday as shareholders absorbed the implications of a Nasdaq Staff Determination letter that brought the company to the edge of a potentially terminal regulatory cliff. The disclosure confirmed what the share price …

Nitish Kishor | 12 May 2026

Ensysce Biosciences Closes Up 9% at $0.38 as CEO Showcases Abuse-Deterrent Opioid Platforms at European Summit

Shares in Ensysce Biosciences (Nasdaq: ENSC) closed 9 per cent higher at $0.38 on Tuesday, as the company placed itself at the centre of one of the most consequential debates in contemporary pharmacology: how to engineer effective pain relief without handing patients or recreational …

Nitish Kishor | 12 May 2026